Cystourethroscopes

Welcome to Cystourethroscopes Site

Cystourethroscopes Resources

Home > Cystourethroscopes > Listen to The Lancet: 21 June

Listen to The Lancet: 21 June

Drug-eluting stents revolutionised interventional cardiology owing to their pronounced ability to reduce restenosis compared with bare-metal stents. Attention has now shifted to safety of these devices because of evidence suggesting an association with late stent thrombosis. In a review, Anthony Bavry and Deepak Bhatt assess current evidence from randomised trials, and propose guidelines for the appropriate use of drug-eluting stents in clinical practice. Deepak Bhatt discusses the history of stents and assesses our current knowledge and considers treatment options for cardiologists and patients in this week's podcast.

Click Here to read the entire article...

Other Articles:

•

FoldRx Technology Enables Discovery Of Novel Therapeutic Approach For Treating Cystic Fibrosis

FoldRx Pharmaceuticals, Inc. (FoldRx) announced that it has discovered a series of novel drug prototypes that have shown potential in vitro to correct the protein-folding defect associated with cystic fibrosis (CF). The discovery, made through a research collaboration announced last year with Cystic Fibrosis Foundation Therapeutics, Inc.

Click Here to read the entire article...

•

Cell Biologists Hail Senate Passage of Stem Cell Bill

Expanding the number of human embryonic stem cells available for use by U.S. government-funded researchers was approved by the Senate with its passage of H.R. 810, 63 - 37. American Society for Cell Biology President Mary Beckerle praised the United

Click Here to read the entire article...

•

ZOOM Rhythm Trak RT 123 drum machine

£10.00 (0 Bid)
End Date: Wednesday Aug-06-2008 18:03:21 BST
Bid now | Add to watch list

Click Here to read the entire article...

•

Medtech Startups, November 2007

New medical technologies represented in companies added (November 2007) to the Medtech Startups Database and/or added to the November 2007 issue of MedMarkets.

The following are brief technology descriptions for companies newly added to the MedMarket Diligence Medtech Startups Database and/or covered in MedMarkets Startups during the month of November:

Development of a miniature retrievable pump for use in improving blood flow following coronary artery angioplasty.
Technology for anchoring dynamic and static spinal implants.
Intervertebral disc and facet joint prosthesis in spine surgery.
Static compression device technology in spine surgery.
Intramedullary transillumination apparatus for use in bone repair.
Company has licensed technology from major technology university that creates colony of liver cells that can be used for testing drug toxicity.
Diagnostic and therapeutic tools for the treatment of patients who are prone to develop unstable coronary syndromes due to the presence of multiple thrombogenic vulnerable plaques.
Device for treatment of chronic renal insufficiency.
Developing the brachytherapy applicator for radiation following lumpectomy.
Development of catheters and other technologies for the treatment of acute and chronic total occlusion in coronary and peripheral arteries.
Stents and stent sleeves that minimize embolism.

Now Published!: Worldwide Wound Management 2007-2016. see link

For coverage in specific issues of MedMarkets, see link.

For details on the Medtech Startups Database, see link.

Tags: medtech, startup

Click Here to read the entire article...

•

Impotence drugs help treat brain tumors: study (Reuters)

Reuters - Impotence drugs may help carry cancer-fighting drugs through the brain to treat malignant tumors, U.S. researchers reported on Monday.

Click Here to read the entire article...

•

[Neuroscience] Quantifying neuronal network dynamics through coarse-grained event trees

Animals process information about many stimulus features simultaneously, swiftly (in a few 100 ms), and robustly (even when individual neurons...

Click Here to read the entire article...